Viera Lukacova

Recent appearances

• 

  Clinical Track: All-Presenter Panel Discussion

  February 16, 2023 · 📺 Simulations Plus, Inc.

  Session panelists include: Naveed Shaik, Gilead, Viera Lukacova, Dr. Rajanikanth Madabushi, U.S. FDA, Elizabeth Ludwig, Sandra Suarez-Sharp, Manuel Ibarra, University of the Republic Uruguay. Session moderator: Tom Sun Learn more about Viera Lukacova here: https://www.simulations-plus.com/peop... Learn more about Elizabeth Ludwig here: https://www.simulations-plus.com/peop... Learn more about Sandra Suarez-Sharp here: https://www.simulations-plus.com/peop...

  Watch on YouTube ↗

• 

  Clinical Track: 2023 DDI Standards Model Update

  February 15, 2023 · 📺 Simulations Plus, Inc.

  Presented by Viera Lukacova at MIDD+ 2023 on Wednesday, February 15th. Learn more about Viera Lukacova here: https://www.simulations-plus.com/peop... Session Moderator: Tom Sun

  Watch on YouTube ↗

• 

  MembranePlus™ Webinar - Getting the Most out of Your In Vitro Permeability Studies

  August 24, 2022 · 📺 Simulations Plus, Inc.

  In this video, Dr. Viera Lukacova discusses how to get the most out of your in vitro permeability assays with MembranePlus™. For more info visit: https://www.simulations-plus.com/soft...

  Watch on YouTube ↗

• 

  Human-on-a-Chip Webinar Hosted by SimulationsPlus and Hesperos

  May 13, 2021 · 📺 Hesperos Inc

  Dr. James Hickman, Chief Scientist at Hesperos, and Dr. Viera Lukacova, Chief Scientist at SimulationsPlus, discuss how data from our Human-on-a-Chip systems combined with GastroPlus PB/PK modeling can accurately predict clinical outcomes. https://www.simulations-plus.com/reso... #drugdiscovery #drugtesting #organonachip #humanonachip #hesperos #simulationsplus #pkpd #clinical #pharmaceuticals #webinar

  Watch on YouTube ↗

• 

  GastroPlus® Lecture Series Part III DDI Predictions with Viera Lukacova

  August 20, 2020 · 📺 Simulations Plus, Inc.

  This GastroPlus® webinar hosted by Viera Lukacova, Director of Simulation Sciences, provides an overview of modeling and simulation in DDI risk assessment in the early discovery stage through regulatory interactions. The objectives of this complimentary lecture are to: (1) Provide an overview of metabolism- and transporter-based DDI modeling capabilities in GastroPlus simulation software (1) Discuss "best practices" in the development and validation of PBPK models for DDI predictions to support regulatory decision-making (2) Share case examples applying PBPK modeling and simulation that highl…

  Watch on YouTube ↗

• 

  GastroPlus® “Workshop from Home” April 14 Special population predictions with Viera Lukacova

  June 23, 2020 · 📺 Simulations Plus, Inc.

  For more information visit: https://www.simulations-plus.com/software/gastroplus/

  Watch on YouTube ↗

• 

  Physiologically Based Pharmacokinetic Modelling for First‑In‑Human Predictions

  November 21, 2019 · 📺 Simulations Plus, Inc.

  This webinar provides an overview of a recent publication on physiologically based pharmacokinetic (PBPK) modeling in first in human (FIH) predictions, and this was a collaborative effort from GastroPlus® User Group members. Physiologically based pharmacokinetic modeling is routinely used during drug discovery for in-vitro to in-vivo translation and pharmacokinetic modeling in preclinical species. This leads to the application of verified models for first-in-human pharmacokinetic predictions. A consistent cross-industry strategy in this application area would increase confidence in the approac…

  Watch on YouTube ↗

• 

  What's New in GastroPlus PBPK Modeling v9.0?

  July 02, 2015 · 📺 Simulations Plus, Inc.

  This informative webinar covers the new PBPK modeling features in the latest version of GastroPlus™ 9.0 from Simulations Plus. Presented by Dr. Viera Lukacova of Simulations Plus, Inc.

  Watch on YouTube ↗